Dr. Christoph von der Goltz

Global Head of Medicine for Mental Health and Emerging Areas
Boehringer Ingelheim

Board certified psychiatrist with over 10 years of clinical experience in neurology and psychiatry and academic research in pre-clinical, clinical, and public health projects in Germany and Sweden. Joined H. Lundbeck A/S, headquartered in Copenhagen, in 2012 with different global leadership roles in Medical Affairs, Health Economics and Clinical Development. Since 2022 with Boehringer Ingelheim in Germany and since 2023 Global Head of Medicine for Mental Health and Emerging Areas.